Elliptic, Quantexa and Speechmatics named among the 25 fastest growing technology businesses in the UK. 

Read more

Odin Vision, a UCL Technology Fund portfolio company has received a grant to accelerate its cutting edge AI technology to fight bowel cancer. Odin Vision’s technology assists doctors to detect and characterise cancerous and pre-cancerous polyps during colonoscopy procedures.

Read more

Quantexa, the Contextual Decision Intelligence and financial data analytics company is ranked No.14 on The Sunday Times Tech Track 100.  

Read more

Pando, a messaging startup for doctors strikes a deal with the British Army to give thousands of troops deployed overseas access to medical expertise. Army medics have already sent more than 120,000 messages through the Pando app. 

Read more

Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016. 

Read more

Quantexa, AlbionVC portfolio company named among the 15 leading European AI start-ups by the Business Insider. Quantexa uses artificial intelligence and big data to help banks and other major institutions to detect fraud. To date the company has raised $23.3 million. 

Read more

Aridhia, an AlbionVC portfolio company has set up International Covid-19 Data Research Alliance and Workbench to unite leading life science, philanthropic and research organisations to respond to the global pandeminic. 

Read more

Discover how AlbionVC and UCL Technology Fund portfolio companies within the AI space are responding to the pandemic. 

Read more